BSEM · BioStem Technologies, Inc. · Metrics
$1.33
-0.18 (-11.92%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, substantial doubt exists about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements.”View the 10-Q filed Aug 12, 2026
Market Cap
$26.95M
Shares
17.85M
Volume · Oct 29
259.49K
Avg daily vol (3M)
150.07K
BSEM metrics
66 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$1.29
Market cap
$26.95M
Price action
20 metricsPrice change (1W)
-10.1%
Price change (30D)
-60.6%
Price change (3M)
-54.1%
Price change (6M)
-66.8%
Price change (YTD)
-60.4%
Price change (1Y)
-66.4%
Trailing year
Price change (5Y)
+4.9%
52-week high
$8.20
52-week low
$1.48
Change from 52-week high
-81.6%
Change from 52-week low
+2.0%
Annualized volatility
120.3%
Annualized volatility (3M)
117.9%
Beta
1.3
RSI (14D)
26.7
Price vs SMA 50
-52.4%
Price vs SMA 200
-64.3%
Avg volume (3M)
146,296
Relative volume
2.3
Average dollar volume
$480,997
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
17.85M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.6×
reciprocal yield 173.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.8×
reciprocal yield 128.3%
P / book
1.0
reciprocal yield 102.5%
FCF yield
-32.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-105.0%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
79.9%
Operating margin
-67.5%
Trailing 12 months
Net margin
-81.8%
Gross profit (TTM)
$27.65M
Operating profit (TTM)
−$23.34M
Net income (TTM)
−$28.29M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-25.5%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-27.9%
Year over year
Net income growth YoY
-84,631.8%
Revenue (TTM)
$34.59M
Trailing 12 months
EPS growth YoY
-127.3%
Shares change YoY
-26.0%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-102.4%
Return on assets
-58.0%
Debt / equity
0.0
Current ratio
1.0
EBITDA (TTM)
−$22.00M
Free cash flow (TTM)
−$8.83M
Quick ratio
0.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$6.96M
Latest balance sheet
Cash & equivalents
$6.96M
Total assets
$48.82M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$5.92M
Capital expenditures (TTM)
$2.91M
R&D (TTM)
$5.31M
SG&A (TTM)
—
Stock compensation (TTM)
$4.67M
R&D / revenue
15.4%
Stock compensation / revenue
13.5%
Ownership (13F)
9 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
1.9%
Latest settlement · 3.0 days to cover
Days to cover
3.0d
Short-squeeze score
55 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged